Cargando…
Procyanidin trimer C1 reactivates latent HIV as a triple combination therapy with kansui and JQ1
Although anti-retroviral therapies have greatly extended the lives of HIV infected individuals, current treatments are unable to completely eliminate virally infected cells. A number of latency reversing agents have been proposed for use in a “shock and kill” strategy to reactivate latent HIV, thus...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258234/ https://www.ncbi.nlm.nih.gov/pubmed/30475902 http://dx.doi.org/10.1371/journal.pone.0208055 |